Evaluation of zonulin, a marker of intestinal permeability as a novel biomarker in polycystic ovary syndrome
Polycystic ovary syndrome (PCOS), a common reproductive disorder with a variety of clinical manifestations such as menstrual irregularities, signs of androgen excess, and infertility, is now considered not only as an endocrine disorder but also as a complex, multifaceted syndrome with substantial long-term health implications and several adverse metabolic, cardiovascular alterations including metabolic syndrome, obesity, dyslipidemia, insulin resistance, diabetes mellitus and coronary artery disease risks in the life span.
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: G. Anik Ilhan, B. Yildizhan Tags: Poster session Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Eating Disorders & Weight Management | Endocrinology | Heart | Infertility | Insulin | Men | Metabolic Syndrome | Obesity | Ovaries | Polycystic Ovary Syndrome | Reproduction Medicine